Carl June
Direktor/Vorstandsmitglied bei AC IMMUNE SA
Vermögen: 20 954 $ am 30.04.2024
Profil
Carl H.
June is the founder of Tmunity Therapeutics, Inc. He currently holds multiple positions including Director at the American Association for Cancer Research, Director at The Parker Institute For Cancer Immunotherapy, Independent Non-Executive Director at AC Immune SA, and Senior Advisor at Arsenal Capital Management LP.
Previously, he worked as an Advisor at Signature Capital LLC and GBP Capital.
Dr. June obtained his doctorate degree from Baylor College of Medicine in 1979 and his undergraduate degree from the United States Naval Academy in 1975.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
AC IMMUNE SA
0,01% | 01.03.2024 | 9 150 ( 0,01% ) | 20 954 $ | 30.04.2024 |
Aktive Positionen von Carl June
Unternehmen | Position | Beginn |
---|---|---|
AC IMMUNE SA | Direktor/Vorstandsmitglied | 20.11.2020 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Gründer | - |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | 01.01.2018 |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Direktor/Vorstandsmitglied | - |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Berater | - |
Ehemalige bekannte Positionen von Carl June
Unternehmen | Position | Ende |
---|---|---|
Signature Capital LLC
Signature Capital LLC Investment ManagersFinance Founded in 1997, Signature Capital LLC is a venture capital firm located in Naples, Florida with an additional office in Portland, Maine | Corporate Officer/Principal | - |
GBP Capital
GBP Capital Investment ManagersFinance Founded in 2005, GBP Capital is a venture capital firm located in Greenwich, Connecticut. | Private Equity Investor | - |
Ausbildung von Carl June
United States Naval Academy | Undergraduate Degree |
Baylor College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Private Unternehmen | 6 |
---|---|
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Finance |
Signature Capital LLC
Signature Capital LLC Investment ManagersFinance Founded in 1997, Signature Capital LLC is a venture capital firm located in Naples, Florida with an additional office in Portland, Maine | Finance |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
GBP Capital
GBP Capital Investment ManagersFinance Founded in 2005, GBP Capital is a venture capital firm located in Greenwich, Connecticut. | Finance |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |